Repligen Corporation
RGEN · NASDAQ
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 801.54M | 455.71M | 224.67M | 185.96M | 3.35 |
| 2023 FY | 632.36M | 278.44M | 47.70M | 35.60M | 0.64 |
| 2024 FY | 634.44M | 274.65M | -35.11M | -25.51M | -0.46 |
| 2025 FY | 738.26M | 347.62M | 59.58M | 48.89M | 0.87 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 2.53B | 620.90M | 523.46M | 422.96M | 1.91B |
| 2023 FY | 2.83B | 866.34M | 751.32M | 711.80M | 1.96B |
| 2024 FY | 2.83B | 856.95M | 757.36M | 686.25M | 1.97B |
| 2025 FY | 2.95B | 843.57M | 566.02M | 689.95M | 2.11B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 172.08M | -133.35M | 38.74M | — | -80.36M |
| 2023 FY | 113.92M | -38.99M | 74.93M | — | 227.87M |
| 2024 FY | 175.39M | -32.91M | 142.49M | — | 6.03M |
| 2025 FY | 117.42M | -23.52M | 93.90M | — | -191.33M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 9.39B | 9.29B | — | — | — |
| 2023 FY | 10.02B | 9.98B | — | — | — |
| 2024 FY | 8.05B | 7.98B | — | — | — |
| 2025 FY | 9.21B | 9.34B | — | — | — |
| 2026-12-31 | — | — | — | — | — |
| 2027-12-31 | — | — | — | — | — |
| 2028-12-31 | — | — | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q2 | 182.37M | 91.14M | 13.90M | 14.87M | 0.26 |
| 2025 Q3 | 188.81M | 100.52M | 16.83M | 14.91M | 0.27 |
| 2025 Q4 | 197.91M | 93.44M | 18.56M | 13.29M | 0.23 |
| 2026 Q1 | 194.26M | 98.48M | 17.99M | 8.33M | 0.15 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q2 | 2.90B | 839.89M | 708.86M | 686.06M | 2.06B |
| 2025 Q3 | 2.92B | 840.62M | 748.75M | 688.87M | 2.08B |
| 2025 Q4 | 2.95B | 843.57M | 566.02M | 689.95M | 2.11B |
| 2026 Q1 | 2.93B | 825.31M | 582.65M | 687.62M | 2.11B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | 28.61M | -7.61M | 21.00M | — | 11.63M |
| 2025 Q3 | 48.10M | -5.39M | 42.71M | — | 39.89M |
| 2025 Q4 | 25.70M | -8.66M | 17.05M | — | -182.73M |
| 2026 Q1 | 28.30M | -4.95M | 23.35M | — | 16.63M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q2 | 6.99B | 6.96B | — | — | — |
| 2025 Q3 | 7.51B | 7.45B | — | — | — |
| 2025 Q4 | 9.26B | 9.39B | — | — | — |
| 2026 Q1 | 6.64B | 6.74B | — | — | — |
| 2026-06-30 | — | — | — | — | — |
| 2026-09-30 | — | — | — | — | — |
| 2026-12-31 | — | — | — | — | — |